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Abstract 
BACKGROUND: Neonatal sepsis is a health problem because it causes serious morbidity and mortality in 
neonate intensive care units. The susceptibility of neonates occurs due to the immaturity of immune system 
development as well as due to maternal and environmental risk factors that can cause infection. Identification of 
genetic variation in genes involved in the inflammatory process can help clarify the pathophysiology of sepsis in 
high-risk patients, useful for the development of new diagnostic tools, and specific management plans for more 
accurate predictions of patient’s prognosis.  
AIM: This study aims to determine the association between gene polymorphism of BPI rs4358188, CD14 
rs2569190, IL1β rs1143643 or MMP16 rs2664349 and the incidence of neonatal sepsis. 
METHODS: Cross-sectional observational studies with genomic DNA samples from infants with sepsis and non-
sepsis which were stored according to the standard storage of genetic materials in the Biomedical Laboratory of 
Faculty of Medicine Universitas Andalas Padang City, Indonesia. This study is part of a previous study by 
Rukmono P. Continued with PCR examination, sequencing and bioinformatics analysis. 
RESULTS: Only IL1β rs1143643 G > A gene polymorphism was associated with the incidence of neonatal sepsis 
and was statistically significant (p = 0.017). No significant association was found between gene polymorphisms of 
BPI rs4358188 G > T, CD14 rs2569190 A>G or MMP16 rs2664349 G > A and neonatal sepsis (p > 0.05). 
CONCLUSION: Gene polymorphism of IL1β rs1143643 G > A is associated with the incidence of neonatal sepsis. 
 
 
 
 
Introduction 
 
Neonatal sepsis is a health problem because 
it causes severe morbidity and mortality in neonate 
intensive care units. The susceptibility of neonates is 
due to immaturity in the development of an immune 
response or due to maternal and environmental risk 
factors that can cause infection [1]. 
The World Health Organization (WHO) 
estimates 1 million deaths each year from neonatal 
sepsis and 42% of these deaths occur within the first 
week of life [2]. The incidence of neonatal sepsis in 
the United States ranges from 1 to 4 per 1000 live 
births and from 2.4 to 16 per 1000 live births in 
Southeast Asia. In Indonesia, the neonatal mortality 
rate caused by infection and sepsis reached 1 to 10 
per 1000 live births and reached 13 to 27 per 1000 
live births in babies born under 1500 g [3]. 
The cause of neonatal sepsis is multifactorial 
and could have a maternal, neonatal or environmental 
basis. In recent years, many studies have investigated 
the association of genetic variation to the incidence of 
neonatal sepsis. Study into the association of genetic 
variation to neonatal sepsis is very important because 
identifying genetic variations in genes that are 
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involved in bacterial-induced cell responses and those 
associated with the pathogenesis of sepsis can help 
clarify the pathophysiology of sepsis in a group of 
high-risk patients. It is useful for the development of 
new diagnostic tools and specific management plans 
for more accurate prediction of patient prognosis [1]. 
To find treatment solutions for neonatal sepsis 
incidence, further studies on aspects of the immune 
system need to be carried out, primarily associated 
with the inflammatory process. Several genes that are 
considered to be associated with it and have not been 
explicitly studied in Indonesia are Bactericidal 
Permeability Increasedasing Protein (BPI), Cluster of 
Differentiation 14 (CD14), Interleukin 1 Beta (IL1β) 
and Matrix Metalloproteinase-16 (MMP16).  
This study aims to reveal the association of 
gene polymorphism of BPI rs4358188, CD14 
rs2569190, IL1β rs114364003 and MMP16 rs2664349 
with the incidence of neonatal sepsis. 
 
 
Material and Methods 
 
Study design and research sample 
The study is an observational study with a 
cross-sectional design using genomic DNA extraction 
samples from sepsis and non-sepsis infants which 
were stored according to standards for genetic 
material in the Biomedical Laboratory of FK UNAND. 
The materials used in the study are part of a previous 
study by Rukmono P. The Team of Research Ethics 
Committee approved the study, Faculty of Medicine, 
Universitas Andalas, Padang No: 532/KEP/FK/2017. 
 
Operational definitions 
The variables of this study included several 
independent variables: Gene Polymorphism of 
Bactericidal Permeability Increasing Protein 
rs4358188, Cluster of Differentiation 14 rs2569190, 
Interleukin 1β rs1143643 and Matrix 
Metalloproteinase-16 rs2664349; and a dependent 
variable is neonatal sepsis.  
 
Research procedure  
The criteria for neonatal sepsis which is used, 
is the presence of clinical symptoms of infection 
confirmed by positive blood culture results indicating 
bacteremia. The samples are then carried out by PCR 
examination, electrophoresis, DNA restriction, 
sequencing, and bioinformatic analysis. 
 
 
Data analysis 
The analysis was performed using the chi-
square test to determine the association between 
gene polymorphism and neonatal sepsis, with a level 
of p < 0.05 considered as statistically significant. Data 
analysis was carried out by using STATA 14.2 (Stata 
Corporation). 
 
 
Results 
 
The samples obtained were from 30 neonates 
with neonatal sepsis and 30 neonates with unproven 
neonatal sepsis (controls) (Table 1).  
Table 1: Demographic characteristics of study subjects 
 
Variable 
Neonates 
p Proven sepsis 
(n = 30) 
Unproven sepsis 
(n = 30) 
Gender 
Male 
Female 
 
15 (50.00%) 
15 (50.00%) 
 
23 (76.67%) 
7 (23.33%) 
 
0.061 
Age 
< 3 days 
≥ 3 days 
 
26 (86.67%) 
4 (13.33%) 
 
29 (96.67%) 
1 (3.33%) 
 
0.353 
BW 
≤ 2500 g 
> 2500 g 
 
9 (30.00%) 
21 (70.00%) 
 
12 (40.00%) 
18 (60.00%) 
 
0.588 
APGAR score at 1 minute 
≤ 3 
> 3 
 
1 (3.33%) 
29 (96.67%) 
 
0 (0.00%) 
30 (100%) 
 
1.000 
Gestational age 
28–31 weeks 
32–35 weeks 
36–38 weeks 
≥ 38 weeks 
 
2 (6.67%) 
4 (13.33%) 
8 (26.67%) 
16 (53.33%) 
 
3 (10.00%) 
8 (26.67%) 
8 (26.67%) 
11 (36.67%) 
 
0.483 
Maternal fever (≥ 38°C) 
Yes 
No 
 
14 (46.67%) 
16 (53.33%) 
 
13 (43.33%) 
17 (56.67%) 
 
1.000 
Thick-smelling amniotic fluid 
Yes 
No 
 
16 (53.33%) 
14 (46.67%) 
 
8 (26.67%) 
22 (73.33%) 
 
0.065 
 
Table 1 showed the demographic 
characteristics, consisting of gender, birth weight, 
APGAR score at first minute, gestational age, and 
occurrence of maternal fever and presence of thick-
smelling amniotic fluid.  
Table 2: Clinical symptoms in study subjects 
Clinical symptoms in 
study subjects 
Neonates p 
Proven sepsis 
(n = 30) 
Unproven sepsis 
(n = 30) 
Crying 
Strong 
Moaning 
Unreacted 
 
23 (76.67%) 
6 (20.00%) 
1 (3.33%) 
 
26 (86.67%) 
4 (13.33%) 
0 (0%) 
 
0.453 
Suction reflex 
Strong 
Weak 
Vomiting 
Nothing 
 
14 (46.67%) 
14 (46.67%) 
1 (3.33%) 
1 (3.33%) 
 
19 (63.33%) 
10 (33.33%) 
1 (3.33%) 
0 (0%) 
 
0.489 
Seizure 
Yes 
No 
 
1 (3.33%) 
29 (96.67%) 
 
1 (3.33%) 
29 (96.67%) 
 
1.000 
Lethargy 
Yes 
No 
 
13 (43.33%) 
17 (56.67%) 
 
6 (20.00%) 
24 (80.00%) 
 
0.096 
Chest retraction 
Yes 
No 
 
8 (26.67%) 
22 (73.33%) 
 
4 (13.33%) 
26 (86.67%) 
 
0.333 
 
Obtained more neonates aged < 3 days 
(86.67%) who suffered sepsis compared to neonates 
aged ≥ 3 days (13.33%) and more neonates born with 
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thick-smelling amniotic fluid (53.33%) had proven 
sepsis although not statistically significant (p > 0.05). 
Clinical symptoms in study subjects (Table 2). 
Table 2 showed the clinical symptoms of the 
study subjects which included crying, suction reflexes, 
seizures, lethargy, and chest retraction, and there was 
no statistically significant association between these 
characteristics (p > 0.05), (Table 3). 
Table 3: Gene polymorphism of BPI, CD14, IL1β, and MMP16 
Type of mutation Allele f % 
BPI rs4358188 G > A 
AA (homozygous) 
GA (heterozygous) 
GG (wild type) 
7 
23 
30 
11.67 
38.33 
50.00 
CD14 rs2569190 A > G 
GG (homozygous) 
AG (heterozygous) 
AA (wild type) 
17 
34 
9 
28.33 
56.67 
15.00 
IL-1β rs1143643 G > A 
AA (homozygous) 
GA (heterozygous) 
GG (wild type) 
16 
29 
15 
26.67 
48.33 
25.00 
MMP16 rs2664349 G > A 
AA (homozygous) 
GA (heterozygous) 
GG (wild type) 
35 
24 
1 
58.33 
40.00 
1.67 
 
Table 3 known, only three SNPs were found 
in this study population, namely CD14, IL1β, and 
MMP16 gene polymorphism, and no BPI gene 
polymorphism was found. Association of genetic 
polymorphism with neonatal sepsis (Table 4). 
Table 4: Association of genetic polymorphism with neonatal 
sepsis 
Gene and allele of the 
polymorphism 
Group 
p 
No sepsis % Sepsis % 
BPI rs4358188 G > T 
No mutations 
Mutation 
 
15 
15 
 
25.0 
25.0 
 
15 
15 
 
25.0 
25.0 
1.00 
CD14 rs2569190 A > G 
No mutations 
Mutation 
 
3 
27 
 
5.00 
45.0 
 
6 
24 
 
10.0 
40.0 
0.472 
IL1β rs1143643 G > A 
No mutations 
Mutation 
 
12 
18 
 
20.0 
30.0 
 
3 
27 
 
5.0 
45.0 
0.017 
MMP16 rs2664349 G > A 
No mutations 
Mutation 
 
1 
29 
 
1.67 
48.33 
 
0 
30 
 
0 
50.0 
1.00 
 
Table 4 showed the four SNPs in the study 
samples that were proven or unproven to have sepsis. 
Only gene polymorphism of IL1β rs1143643 G > A 
was associated with the incidence of neonatal sepsis 
and was statistically significant (p < 0.05). However, 
no significant association was found between gene 
polymorphism of BPI rs4358188 G > T, CD14 
rs2569190 A > G or MMP16 rs2664349 G > A and 
neonatal sepsis (p > 0.05). 
 
 
Discussion 
 
Identification of genetic variation in neonatal 
sepsis is essential because infants, especially those 
with very low birth weights (VLBW) or born 
prematurely, have immature immune systems and 
innate immunity to bacterial infections is disrupted. 
This causes infants to be at risk of sepsis or severe 
sepsis. Therefore, identification of these genetic 
variations can help to clarify sepsis pathophysiology in 
a group of high-risk patients. 
About demographic characteristics of the 
study subjects, no significant association was found 
between these characteristics and neonatal sepsis. 
There was no significant association between gender 
and neonatal sepsis (p > 0.05). This result contrasts 
with the results of Shivaprasad B’s study in which 
male infants had sepsis risk factors that were 3.1-fold 
higher than female infants. Shane L. Andi also found a 
higher incidence of sepsis in term male infants than 
term female infants, although this association has not 
been found in premature infants [4]. Sepsis is 
multifactorial, and inflammatory cytokine effects on 
sepsis development can be modified by age, gender, 
and several environmental factors. 
In the age group of the study subjects, no 
significant association was found (p > 0.05). Neonatal 
sepsis is divided into two categories based on time of 
onset, namely neonatal early-onset sepsis (EOS) if 
symptoms occur at < 72 hours, and neonatal late-
onset sepsis (LOS) if symptoms occur at ≥ 72 hours. 
The incidence of neonatal early-onset sepsis is 
reported to be 0.98 infections per 1000 live births [4]. 
While the estimated number of LOS cases nationally 
is unknown. 
About the birth weight group, there were no 
significant differences in the sepsis and non-sepsis 
groups regarding birth weight (p > 0.05). The 
incidence of sepsis was inversely proportional to birth 
weight, namely 10.96 per 1000 live births with a birth 
weight of 401 – 1500 g, 1.38 for 1501 – 2500 g, and 
0.57 for > 2500 g [4]. 
With regard to the APGAR score at 1 minute, 
one neonate (3.33%) had an APGAR score of ≤ 3 and 
29 neonates (96.67%) a score of > 3 of APGAR score 
in the sepsis sample group, and 0 (0.00%) neonate 
with ≤ 3 of APGAR score and 30 (100.00%) neonates 
with > 3 of APGAR score, with p-value of 1,000, 
showed no significant differences between sepsis and 
non-sepsis groups based on APGAR score at 1 
minute. This is not by the study conducted by 
Gebremedhin D, where the APGAR score at 5 
minutes and shortly after birth showed a significant 
association with the risk of neonatal sepsis. Neonates 
with an APGAR score of < 7 at 5 minutes have a 
higher risk of developing neonatal sepsis than 
neonates with an APGAR score of ≥ 7 (OR = 68.9; 
95% CI 3.63, 1307.90). Similarly, neonates who cry 
immediately at birth are 99% less likely to experience 
sepsis than neonates who do not cry immediately at 
birth (OR = 124.0; 95% CI 6.5, 2379) [5]. This may be 
due to the nature of crying, which is a physiological 
event, and changes associated with this event. 
About gestational age, no significant 
differences were found between sepsis and non-
sepsis groups. Based on the literature, the overall 
case fatality rate of neonatal sepsis is 16%, with an 
incidence that is inversely proportional to gestational 
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age: 54% at 22–24 weeks of gestational age, 30% at 
25 – 28 weeks, 12% at 29 – 33 weeks, and 3% at 
greater than 37 weeks [4]. While for the risk of LOS 
incidence based on gestational age is 36.3% in 
neonates with a gestational age of <  28 weeks at 
least having one episode of LOS compared to 29.6%, 
17.5% and 16.5% in moderate preterm neonates (29–
32 weeks of gestational age), late preterm (33–36 
weeks of gestational age) and a term neonates, 
respectively. 
There was no significant association between 
the maternal fever group during labour (≥ 38°C) and 
the incidence of sepsis (p > 0.05). This was not by the 
results of previous studies, which found that neonates 
born to mothers who had a fever during labour had a 
6-times greater risk of experiencing sepsis than 
neonates born to mothers who did not experience 
intrapartum fever [5], [6]. Intrapartum fever is 
considered to be an indicator of maternal infection 
which is often transmitted to the baby in utero or as it 
passes through the birth canal and often causes EOS. 
Maternal fever without accompanying chorioamnionitis 
signs can also increase the risk of sepsis but is often 
accompanied by a cause of noninfectious maternal 
fever such as dehydration or epidural anaesthesia [7]. 
According to Verma P et al., some maternal factors 
that predispose to sepsis include vaginal 
examinations that are too frequent (23.25%), maternal 
fever (33.33%) and history of foul-smelling amniotic 
fluid (24.72%) [8]. 
In the sepsis group, 16 neonates (53.33%) 
were from mothers with thick-smelling amniotic fluid 
and 14 neonates (46.67%) from mothers without a 
history of thick-smelling amniotic fluid. Whereas in the 
unproven sepsis group, there were eight neonates 
(26.67%) from mothers with thick-smelling amniotic 
fluid and 22 (73.33%) from mothers without a history 
of thick-smelling amniotic fluid (p > 0.05). The results 
of this study are consistent with two previous studies 
which reported that foul-smelling amniotic fluid, 
prematurity, low birth weight, residency, parity, and 
ANC facility services were not statistically associated 
with the risk of neonatal sepsis. However, regarding 
absolute numbers of sepsis cases, there was a higher 
incidence of thick-smelling amniotic fluid and vice 
versa [5]. Rawat S. also reported that the discovery of 
foul-smelling amniotic fluid is evidence of anaerobic 
bacteria and is one of the predisposing factors for 
sepsis, but there is insufficient evidence confirm this 
as an independent risk factor for neonatal sepsis [7]. 
Clinical symptoms were examined in this 
study, including crying, suction reflexes, seizures, 
lethargy and chest retraction. After statistical analysis, 
no significant differences were found in the group that 
was proven to have sepsis or not proven to have 
neonatal sepsis against crying (p = 0.453), suction 
reflexes (p = 0.489), seizures (p = 1.000), lethargy (p 
= 0.096) and chest retraction (p = 0.333). This 
suggests that both groups had almost the same 
clinical symptoms, so it does not affect the results of 
the study. 
About BPI rs4358188 gene polymorphism in 
the sepsis group (30 subjects), 12 subjects 
experienced heterozygous polymorphism (GA) of the 
rs4358188 BPI gene, three subjects with homozygous 
polymorphisms (AA) and 15 wild-types (GG) subjects. 
Whereas in the no sepsis group (30 subjects), 11 
subjects experienced heterozygous polymorphisms 
(GA) of the rs4358188 BPI gene, four subjects with 
homozygous polymorphisms (AA) and 15 wild-types 
(GG) subjects. 
BPI is a gene that encodes factors that play 
an essential antibacterial and anti-inflammatory role 
and are commonly found in neutrophil azurophilic 
granules, playing an essential role in defence against 
Gram-negative infections. Esposito et al. reported that 
the AG genotype of BPI rs4358188 was associated 
with a reduced risk of sepsis [4]. However, Abu 
Maziad's study did not show an association between 
BPI polymorphisms and susceptibility to sepsis [9]. 
Michalek et al. also reported a negative association 
between BPI SNP and sepsis in children aged 0 – 18 
years where the GG genotype of BPI rs435188 was 
associated with increased susceptibility to severe 
sepsis and adverse perinatal outcomes [10]. 
In the case of polymorphism in the CD14 
rs2569190 gene, 16 subjects experienced 
heterozygous polymorphism (AG) of the rs2569190 
CD14 gene, eight subjects experienced homozygous 
polymorphism (GG), and there were six wild-types 
(AA) subjects in the proven neonatal sepsis group. In 
the unproven neonatal sepsis group (30 subjects), 18 
subjects were found with heterozygous polymorphism 
(AG) of the rs2569190 CD14 gene, nine subjects 
experienced homozygous polymorphism (GG), and 
the remaining three subjects were wild-type (AA). 
CD14 is a component of lipopolysaccharide 
receptor molecules and an important recognition 
receptor that plays a key role in the immune response 
and inflammation. Previous studies have shown that 
CD14 gene polymorphisms are involved in several 
inflammatory diseases, such as ulcerative colitis and 
Crohn's disease. Previous reports have shown that 
the biological association of CD14 rs2569190 gene 
polymorphism with the survival of patients with A 
allele can be caused by a strong pro-inflammatory 
response in patients, along with higher CD14 
expression [11]. 
Studies have shown that GG genotype of 
CD14 rs2569190 gene is associated with an 
increased risk of severe sepsis and death in sepsis 
shock patients undergoing major surgery [1], [11]. 
Patients with GG genotype of rs2569190 had a 
shorter probability of survival compared to AA/AG 
genotype of rs2569190 in 60 days (62.3% vs 50%), 
and 90 days (62.3% vs 52.6%) (p = 0.046) compared 
to AA/AG genotypes. A to G polymorphism at -159 
positions in the region of CD14 (rs2569190) gene 
promotion can cause different activities in promoter 
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arrangement. In this context, the G allele of 
rs2569190 seems to have implications for decreasing 
CD14 transcription regulation and also decreasing 
mCD14 expression and circulating sCD14 levels [11]. 
The study conducted by Wang reported that 
there was no evidence that rs2569190 was associated 
with susceptibility to sepsis [12]. In 2013, a meta-
analysis by Zhang et al. concluded that CD14 
rs2569190 polymorphism was not a relevant risk 
factor for sepsis and mortality. The authors found that 
patients with AA/AG genotype had a higher risk of 
death than patients with the GG genotype (Asian 
population). This finding is likely to be a result of the 
small number of studies associated with sepsis 
mortality that were included in the meta-analysis [13]. 
In the sample group with IL1β gene 
polymorphism, 20 subjects experienced heterozygous 
polymorphism (GA) of rs1143643 IL1β gene, seven 
subjects experienced homozygous polymorphism 
(AA), and the remaining three subjects were wild-type 
(GG). Whereas in the unproven group of neonatal 
sepsis totalling 30 subjects, nine subjects were found 
who experienced heterozygous polymorphism (GA) of 
rs1143643 IL1β gene, nine subjects experienced 
homozygous polymorphism (AA), and the remaining 
12 subjects were wild type (GG). 
Interleukin 1β is a key pro-inflammatory 
cytokine that is produced early in response to 
microbial invasion and plays an important role in the 
pathogenesis of sepsis and sepsis shock. These 
molecules stimulate the production of prostaglandins 
and nitric oxide, the two vasodilatory mediators found 
in sepsis. 
Esposito et al. reported that the CT and TT 
genotypes of IL1β rs1143643 gene were associated 
with a significant increase in the overall risk of sepsis 
[4]. The three polymorphisms of IL1β rs1143634, 
rs1143633 and rs1143643 were associated with the 
risk of allergic asthma (p = 0.034, OR = 1.523; p = 
0.024, OR = 1.471; p = 0.044, OR = 1.420) [14]. The 
study by Abu Maziad et al. did not find an association 
between IL1β gene polymorphism and sepsis. This 
discrepancy may be due to differences in the 
definition of sepsis and its severity, and differences in 
some general characteristics of the subjects, included 
ethnicity, compared to those used in Esposito’s study 
[9]. 
Concerning MMP16 gene polymorphism, 12 
subjects experienced heterozygous polymorphism 
(GA) of the rs2664349 MMP16 gene, 18 subjects 
experienced homozygous polymorphism (AA), and 
there were no subjects with wild type (GG). In the 
unproven neonatal sepsis group, totalling 30 subjects, 
12 subjects experienced heterozygous polymorphism 
(GA) of the rs2664349 MMP16 gene, 17 subjects who 
experienced homozygous polymorphism (AA) and one 
wild type (GG) subject. 
One of the advantages of the PCR 
sequencing method the detection of other nucleotides 
besides the nucleotide targets, for example, SNP 
MMP16 rs2616505 A > G, rs11785236 A > G, and 
rs10504853 T > G; these were also found in this study 
and SNP has not been studied previously in 
Indonesia. 
The results of this study on increasing MMP 
expression after exposure to LPS indicate that 
protease can affect the pathogenesis of endotoxemia 
so that MMP levels are said to be associated with 
sepsis severity. In this study, MMP may play a role in 
the incidence of sepsis because almost all samples 
had mutations, although it was not statistically 
significant. MMP is regarded as a time bomb because 
most of the samples had mutations in both sepsis and 
non-sepsis patients. Therefore, currently, MMP-based 
therapy (MMP-inhibitor) is being developed in patients 
with sepsis and sepsis shock, for example, 
glucocorticoids, retinoids and progesterone which can 
suppress MMP expression [4]. 
MMP16 is a zinc-dependent enzyme, and this 
element is very important for the normal functioning of 
the innate or adaptive immune systems [15]. The 
possibility that MMP genetic variation significantly 
affects susceptibility to infectious disease in humans 
is still very small [16]. A consistent discovery to many 
gene expression studies that patients with pediatric 
septic shock are characterised by extensive 
repression of genes that directly participate in zinc 
balance or directly depend on them to perform normal 
functions [17], [18], [19], [20]. 
Esposito et al. reported that the GG genotype 
of rs2664349 was associated with an increased risk of 
significant sepsis. This is the first report of the 
potential effects of MMP16 genetic variation on sepsis 
and seems to be in agreement with recent evidence 
that MMP is, not only a matrix degradation enzyme as 
previously thought, but also has multiple 
immunomodulation mechanisms. SNP rs2664349 not 
only affects pulmonary expression, MMP16 function 
and risk of bronchopulmonary dysplasia in preterm 
infants but also affects to MM2 activation, MMP which 
plays a core role in monocyte chemoattraction and 
subsequently affects the response to infectious agents 
[4], [21].  
In conclusion, this analysis confirmed gene 
polymorphism of IL1β rs1143643 G > A is associated 
with the incidence of neonatal sepsis. 
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